Uptake Medical

18 articles about Uptake Medical

• Uptake Medical Release: InterVapor Bronchoscopic Thermal Vapor Ablation (BTVA) Is Back On The Market

  9/7/2017

• Uptake Medical Release: Intervapor Targeted Ablation Therapy Reported As Superior To Standard Medical Management In The Lancet

  3/1/2016

• Uptake Medical Announces First-In-Human Lung Cancer Tumor Ablation Using Intervapor Targeted Vapor Therapy

  10/12/2015

• Data Confirms Uptake Medical’s InterVapor Significantly Improves Lung Function in Severe Emphysema Patients

  10/2/2015

• Uptake Medical Receives CE Mark Approval For InterVapor Targeted Ablation Therapy For Severe Emphysema

  8/12/2015

• Uptake Medical Announces Positive 12-month Outcome Data for InterVapor Therapy for Severe Emphysema

  5/24/2012

• Uptake Medical Announces Successful Completion of Series C Financing

  1/9/2012

• Uptake Medical Raises $35 Million Cash for Novel Emphysema Treatment

  1/4/2012

• Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema

  12/21/2011

• Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema

  11/29/2011

• Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results

  9/26/2011

• Uptake Medical Expands Executive Team, Announces European General Manager Lloyd Mencinger

  9/6/2011

• Uptake Medical Announces Scott Huennekens Elected to Board of Directors

  3/1/2011

• Uptake Medical Ups and Goes to the O.C., Retains Technical Center in Seattle

  1/31/2011

• Uptake Medical Names J.C. MacRae as Chief Financial Officer

  11/16/2010

• Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer

  11/1/2010

• Uptake Medical Completes Series B Financing Round for $17.5 Million

  7/7/2010

• Uptake Medical Nabs $3.4 Million

  9/14/2009